Visible spectrophotometric methods for the determination of venlafaxine hydrochloride and ritodrine hydrochloride in pharmaceutical formulations

Asian Journal of Chemistry

Volumn 15, Issue 1, 2003, Pages 509-511

  Gowri Sankar, D ^a   Snehalatha, B ^a   Vijayasri, K ^a   Murthy, T K ^a   Kumar, J M R ^a   Reddy, M V V N ^a  

^a ANDHRA UNIVERSITY   (India)

Author keywords

Ritodrine hydrochloride; Spectrophotometric determination; Venlafaxine hydrochloride

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; RITODRINE; VENLAFAXINE;

ANALYTIC METHOD; ARTICLE; DRUG CAPSULE; DRUG DETERMINATION; DRUG FORMULATION; POWDER; SPECTROPHOTOMETRY; TABLET FORMULATION; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0037212075     PISSN: 09707077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. H.P. Rang, M.M. Dale and J.M. Ritter, Pharmacology, 4th Edn., Churchill Livingstone, Edinburg, p. 563 (1999).
2. Drug Facts and Comparisons, A. Wolters Kluwer Company, p. 1644 (1999).
3. Goodman and Gilman. The Pharmacological Basis of Therapeutics, 8th Edn., McGraw-Hill, New York, p. 206 (1990).
4. United States Pharmacopoeia, Vol. XXIV, U.S.P. Convention Inc., Rockville, p. 1493 (2000).
5. S. Rudaz, C. Stella, A.E.B. Georgia, S. Fanali and J.L. Veuthey, J. Pharma. Biomed. Anal., 23, 107 (2000).
6. S. Paterson, C. Rosa, M. Scott and H. Philip, Ann. Clin. Biochem., 37, 690 (2000).
7. H.D. Revanasiddappa and B.G. Manju, J. AOAC. Int., 83, 1440 (2000).
8. V.R. Bari, V.J. Dhorda and M. Sundaresan, Indian Drugs, 36, 679 (1999).
9. C.M. Hernandez, Anal. Chim. Acta, 408, 285 (2000).
10. H.D. Revanasiddappa, B.G. Manju and P.G. Ramappa, Anal. Sci., 15, 661 (1999).
11. A.O. Razak, J. Pharm. Biomed. Anal., 18, 359 (1998).
12. A. Shalaby, H. Salem and A.A. Kheir, Sci. Pharm., 65, 143 (1997).